Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Forxiga
Forxiga
Jardiance cleared in EU for CKD, challenging Forxiga
Pharmaphorum
Wed, 07/26/23 - 09:45 am
Boehringer Ingelheim
Eli Lilly
Jardiance
Europe
chronic kidney disease
Forxiga
AstraZeneca's Forxiga nabs expanded heart failure approval in Europe
Fierce Pharma
Tue, 02/7/23 - 06:41 pm
AstraZeneca
Europe
Forxiga
heart failure
AZ’s diabetes drug Forxiga approved in EU for type 1 disease
Pharmaforum
Mon, 03/25/19 - 10:17 am
AstraZeneca
type 1 diabetes diabetes
Europe
Forxiga
Farixga
AstraZeneca’s Forxiga recommended for marketing authorization in EU
Pharmaceutical Business Review
Mon, 02/4/19 - 09:52 am
EMA
AstraZeneca
Forxiga
type 1 diabetes
CHMP
AstraZeneca, Genzyme sanctioned by UK group for marketing missteps
BioPharma Dive
Thu, 07/7/16 - 09:20 am
AstraZeneca
Genzyme
UK
Forxiga
Fabrazyme
3 Can't-Miss FDA Actions Coming in December
Motley Fool
Tue, 11/26/13 - 04:42 pm
FDA
Gilead Sciences
sofosbuvir
Forxiga
AstraZeneca
Bristol-Myers Squibb
GSK
Anoro Ellipta
Theravance
Groundbreaking Diabetes Drug Headlines Approval Bonanza
Motley Fool
Sun, 09/22/13 - 11:25 am
diabetes
type 2 diabetes
type 1 diabetes
JNJ
inokana
Forxiga
AstraZeneca
Bristol-Myers Squibb
2 Keys to Success for This Diabetes Drug's Second Chance
Motley Fool
Tue, 07/30/13 - 11:35 am
diabetes
AstraZeneca
Bristol-Myers Squibb
Forxiga
The Diabetes Pipeline With a Clog
Motley Fool
Mon, 07/22/13 - 06:02 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
JNJ
SGLT2 inhibitor
Forxiga
Invokana
empagliflozin
AstraZeneca, Bristol-Myers’s Forxiga Not Backed by NICE
Bloomberg
Fri, 02/1/13 - 10:57 am
AstraZeneca
Forxiga
Bristol-Myers Squibb
UK
diabetes
3 Big Stories Health-Care Investors Should Be Watching This Week
Motley Fool
Mon, 01/7/13 - 10:23 am
JNJ
Invokana
SLGT-2 inhibitors
diabetes
Forxiga
Bristol-Myers Squibb
Pfizer
Raptor Pharmaceuticals
AstraZeneca's Forxiga For Type 2 Diabetes Is A Potential Blockbuster
Seeking Alpha
Fri, 11/16/12 - 10:13 am
AstraZeneca
Forxiga
diabetes
Dapagliflozin
Bristol-Myers, AstraZeneca Type 2 diabetes pill gets first major approval, in European Union
Yahoo/AP
Thu, 11/15/12 - 10:46 am
diabetes
Bristol-Myers Squibb
AstraZeneca
Europe
SGLT2 inhibitor
Forxiga